17 results found.

Endometriosis, Botulinum Toxin A, Chronic Pelvic Pain, Pelvic Mus Clinical Trial using Botuninum toxin A

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 50 years.
- The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women With Endometriosis.
Botuninum toxin A

Deep Infiltrating Endometriosis (DIE) Clinical Trial using Triptorelin Acetate 3.75mg intramuscular injection

Ipsen - Recruiting 18 years or older.
- A Multi-centre, Prospective, Non-interventional Study to Describe the Efficacy of a Continuous up to 24-week Treatment of Diphereline 3.75mg Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months..
Triptorelin Acetate 3.75mg intramuscular injection

Endometriosis Clinical Trial using Surgery for endometriosis

The Cleveland Clinic - Recruiting 18 years or older.
- Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial.
Surgery for endometriosis

Endometriosis Clinical Trial using Desogestrel; Placebo capsule

Mahidol University - Recruiting 18 years to 45 years.
- A Prospective Double Blind Randomized Controlled Trial to Study the Effectiveness of a Desogestrel for the Treatment of Pelvic Pain or Dysmenorrhea in the Patients Undergone Conservative Surgery for Pelvic Endometriosis.
Desogestrel; Placebo capsule

Endometriosis Clinical Trial using Dienogest (Visanne, BAY86-5258); Placebo

Bayer - Recruiting 18 years to 45 years.
- A Multicenter Study to Investigate the Efficacy and Safety of Daily Oral Administration of 2 mg Dienogest Tablets (Visanne/SH T00660AA) for the Treatment of Endometriosis in Chinese Patients: a Double-blind, Randomized, Placebo-controlled, Parallel Group Phase Over 24 Weeks Followed by an Open-label, Single-group Follow up Over 28 Weeks.
Dienogest (Visanne, BAY86-5258); Placebo

Endometriosis Clinical Trial

Center for Epidemiology and Health Research, Germany - Recruiting N/A or older.
- International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.

Endometriosis Clinical Trial using Elagolix; placebo

AbbVie - Recruiting 18 years to 49 years.
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain.
Elagolix; placebo

Endometriosis Clinical Trial using Elagolix; placebo

AbbVie - Recruiting 18 years to 49 years.
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain.
Elagolix; placebo

Endometriosis Clinical Trial using Participants will receive ICG Dye

Florida Hospital - Recruiting 18 years to 55 years.
- An Evaluation of Fluorescence Imaging + ICG Dye (Firefly) for Use in the Visual Diagnosis of Endometriosis: A Prospective Study.
Participants will receive ICG Dye

Dysmenorrhea Clinical Trial using Sanjie analgesic capsule; placebo

Jiangsu Kanion Pharmaceutical Co.,Ltd - Recruiting 18 years to 45 years.
- A Randomized, Double-blind, Placebo-controlled Post-marketing Study to Assess the Treatment Effect of Sanjie Analgesic Capsule in Treating Endometriosis - Associated Pain.
Sanjie analgesic capsule; placebo

Endometriosis Clinical Trial using Visanne (Dienogest, BAY86-5258)

Bayer - Recruiting 18 years or older.
- Study to Characterize Patients Treated With Visanne for Their Endometriosis Under Real-life Practice Conditions and Evaluate Their Quality of Life at Baseline and After 6 Months of Treatment With Visanne..
Visanne (Dienogest, BAY86-5258)

Endometriosis Clinical Trial using Visanne (Dienogest, BAY86-5258)

Bayer - Recruiting N/A or older.
- Visanner (Dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea.
Visanne (Dienogest, BAY86-5258)

IVF, or Endometriosis Clinical Trial using blood test

Rennes University Hospital - Recruiting 18 years or older.
- VARITI-5 : Study of Variations of Serum ITIH5 in Women During the Genital Life and in Pathological Situations..
blood test

Endometriosis Clinical Trial using ASP1707; Placebo; Leuprorelin acetate

Astellas Pharma Inc - Recruiting 18 years to 45 years.
- A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Efficacy, Safety, and Dose-Response Relationship of ASP1707 in Subjects With Endometriosis Associated Pelvic Pain for 12 Weeks, Followed by a 12-Week Double-blind Extension Without Placebo Control, Including a 24-Week Open-Label Leuprorelin Acetate Treatment Group for Bone Mineral Density Assessment.
ASP1707; Placebo; Leuprorelin acetate

Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Choriocarcin Clinical Trial

Huazhong University of Science and Technology - Recruiting 18 years to 75 years.
- A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms.

Male Infertility, Female Infertility, Ovarian Hyperstimulation Sy Clinical Trial using patient education; professional audit and feedback (guideline adherence); professional education (communication/shared decision making); information tools

Radboud University - Recruiting 18 years to 80 years.
- Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility.
patient education; professional audit and feedback (guideline adherence); professional education (communication/shared decision making); information tools

Endometriosis Clinical Trial

National Taiwan University Hospital - Recruiting 35 years to 50 years.
- .